Rotavirus Vaccines: Clinical Trials

4 trials for Rotavirus Vaccines, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed. 4 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 34Completed 4

Follow Rotavirus Vaccines: new trials by email Literature Review of Rotavirus Vaccines trials Research Report on Rotavirus Vaccines

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety and Immunological Efficacy of the Pentavalent Rotavirus Vaccine - Rota-V-Aid™ (Live Attenuated Oral, Freeze-dried) at Healthy Adults Aged 18 to 45 Years.
The pentavalent rotavirus vaccine (live attenuated oral, freeze-dried), Placebo - Rotavirus Infections, Rotavirus Vaccines
Phase 3CompletedLimited Liability Company Pharm Aid402018-06-252021-09-08
This Study Will Evaluate the Immunogenicity, Reactogenicity and Safety of the Routine Infant Vaccines Pediarix®, Hiberix® and Prevenar 13® When Co-administered With GlaxoSmithKline (GSK) Biologicals' Liquid Human Rotavirus Vaccine (HRV) as Compared to GSK's Licensed Lyophilized Vaccine
Rotarix, Pediarix, Hiberix - Rotavirus Infection, Rotavirus Vaccines
Phase 3CompletedGlaxoSmithKline12802017-09-142020-12-29
Evaluation of Immunogenicity and Safety of Two Formulations of GSK Biologicals' Human Rotavirus (HRV) Vaccine (444563), in Healthy Infants Starting at Age 6-12 Weeks
HRV PCV-free liquid vaccine, Rotarix - Infections, Rotavirus, Rotavirus Vaccines
Phase 3CompletedGlaxoSmithKline16122016-10-272020-07-21
Efficacy, Safety, Reactogenicity & Immunogenicity of the Rotarix Vaccine in Japanese Infants
Rotarix, Placebo - Infections, Rotavirus, Rotavirus Vaccines
Phase 3CompletedGlaxoSmithKline7652007-06-192020-01-02

Narrower conditions

Rotavirus Infections (4)

Broader conditions

Infections (4)  ·  RNA Virus Infections (4)  ·  Reoviridae Infections (4)  ·  Virus Diseases (4)

Interventions

RIX4414 vaccine (3)  ·  13-valent pneumococcal vaccine (1)  ·  CRM197 (non-toxic variant of diphtheria toxin) (1)  ·  Freeze Drying (1)  ·  Hepatitis B Vaccines (1)  ·  Hiberix (1)  ·  PEDIARIX (1)  ·  Poliovirus Vaccine, Inactivated (1)  ·  Tetanus Toxoid (1)

Sponsors

GlaxoSmithKline (3)  ·  Limited Liability Company Pharm Aid (1)

Countries

Japan (2)  ·  United States (2)  ·  Costa Rica (1)  ·  Finland (1)  ·  Germany (1)  ·  Russia (1)  ·  South Korea (1)  ·  Spain (1)  ·  Taiwan (1)

Top investigators

Irina V. Feldblium, Dr. Sci (1)

Results publications

PMID 34788488

NIH funding

2016 (2), 2015 (1)